Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Gastroenterology
December 17, 2025
Research
December 16, 2025
Research
December 15, 2025
Research
December 15, 2025
Research
December 15, 2025
Cancer
December 10, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community